Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2010 Jun 15;33(6):345–352. doi: 10.1002/clc.20771

Loop Diuretic Therapy in Heart Failure: The Need for Solid Evidence on a Fluid Issue

Jun R Chiong 1,✉, Rebecca J Cheung 1,2
PMCID: PMC6653669  PMID: 20556804

Abstract

Background

Heart failure (HF) is a common condition associated with substantial cost, morbidity, and mortality. Because results of clinical trials in the acute decompensated heart failure (ADHF) setting have been mostly neutral, loop diuretics remain the mainstay of treatment.

Hypothesis

Loop diuretic use may be associated with unfavorable outcomes.

Methods

A MEDLINE literature search was performed to identify articles relating to heart failure and loop diuretics. The current evidence on the risks and benefits of loop diuretics for the treatment of ADHF is reviewed.

Results

Loop diuretics are associated with symptomatic improvements in congestion, urine output, and body weight, but have shown no long‐term mortality benefit. Loop diuretics, especially at high doses, are associated with worsened renal function and other poor outcomes.

Conclusions

Loop diuretics still prove useful in HF treatment, but risk‐benefit analysis of these agents in the treatment of ADHF requires a well‐designed prospective study. Copyright © 2010 Wiley Periodicals, Inc.

Full Text

The Full Text of this article is available as a PDF (358.5 KB).

References

References for Supporting Information Tables 1 and 2

  • 1. Cuffe MS, Califf RM, Adams KF Jr, et al; for OPTIME‐CHF Investigators. Short‐term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002; 287: 1541–1547. [DOI] [PubMed] [Google Scholar]
  • 2. Mebazaa A, Nieminen MS, Packer M, et al; for SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007; 297: 1883–1891. [DOI] [PubMed] [Google Scholar]
  • 3. Silke B. Central hemodynamic effects of diuretic therapy in chronic heart failure. Cardiovasc Drugs Ther 1993; 7: 45–53. [DOI] [PubMed] [Google Scholar]
  • 4. Stevenson LW, Brunken RC, Belil D, et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol 1990; 15: 174–180. [DOI] [PubMed] [Google Scholar]
  • 5. Drug Topics magazine. Table of top 200 generic drugs by total prescriptions, 2008. http://drugtopics.modernmedicine.com/top200gen. Accessed September 24, 2009.
  • 6. Brater DC. Diuretic therapy. N Engl J Med 1998; 339: 387–395. [DOI] [PubMed] [Google Scholar]
  • 7. Rocco TP, Fang JC. Pharmacotherapy of congestive heart failure In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw‐Hill; 2006; 874. [Google Scholar]
  • 8. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985; 103: 1–6. [DOI] [PubMed] [Google Scholar]
  • 9. Nicholls MG. Interaction of diuretics and electrolytes in congestive heart failure. Am J Cardiol 1990; 65: 17E–23E. [DOI] [PubMed] [Google Scholar]
  • 10. Müller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV—efficacy and quality of life. Eur J Heart Fail 2003; 5: 793–801. [DOI] [PubMed] [Google Scholar]
  • 11. Murray MD, Deer MM, Ferguson JA, et al. Open‐label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 2001; 111: 513–520. [DOI] [PubMed] [Google Scholar]
  • 12. Brater DC. Pharmacokinetics of loop diuretics in congestive heart failure. Br Heart J 1994; 72: S40–S43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002; 144: 31–38. [DOI] [PubMed] [Google Scholar]
  • 14. Kramer BK, Schweda F, Riegger GA. Diuretic treatment and diuretic resistance in heart failure. Am J Med 1999; 106: 90–96. [DOI] [PubMed] [Google Scholar]
  • 15. Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005; 3: CD003178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006; 97: 1759–1764. [DOI] [PubMed] [Google Scholar]
  • 17. Ahmed A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006; 27: 1431–1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Ahmed A, Young JB, Love TE, Levesque R, Pitt B. A propensity‐matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure. Int J Cardiol 2008; 125: 246–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007; 9: 1064–1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Philbin EF, Cotto M, Rocco TA Jr, Jenkins PL. Association between diuretic use, clinical response, and death in acute heart failure. Am J Cardiol 1997; 80: 519–522. [DOI] [PubMed] [Google Scholar]
  • 21. Peacock WF, Costanzo MR, De Marco T, et al; for ADHERE Scientific Advisory Committee and Investigators. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 2009; 113: 12–19. [DOI] [PubMed] [Google Scholar]
  • 22. Wright SP, Verouhis D, Gamble G, Swedberg K, Sharpe N, Doughty RN. Factors influencing the length of hospital stay of patients with heart failure. Eur J Heart Fail 2003; 5: 201–209. [DOI] [PubMed] [Google Scholar]
  • 23. Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53: 589–596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–1435. [DOI] [PubMed] [Google Scholar]
  • 25. Fonarow GC, Adams KF Jr, Abraham WT, et al; for ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in‐hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005; 293: 572–580. [DOI] [PubMed] [Google Scholar]
  • 26. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990; 82: 1724–1729. [DOI] [PubMed] [Google Scholar]
  • 27. Bayliss J, Norell M, Canepa‐Anson R, Sutton G, Poole‐Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987; 57: 17–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Galve E, Mallol A, Catalan R, et al. Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction. Eur J Heart Fail 2005; 7: 892–898. [DOI] [PubMed] [Google Scholar]
  • 29. Jaronik J, Mikkelson P, Fales W, Overton DT. Evaluation of prehospital use of furosemide in patients with respiratory distress. Prehosp Emerg Care 2006; 10: 194–197. [DOI] [PubMed] [Google Scholar]
  • 30. Van Kraaij DJ, Jansen RW, Gribnau FW, Hoefnagels WH. Use of diuretics and opportunities for withdrawal in a Dutch nursing home population. Neth J Med 1998; 53: 20–26. [DOI] [PubMed] [Google Scholar]
  • 31. Mosesso VN Jr, Dunford J, Blackwell T, Griswell JK. Prehospital therapy for acute congestive heart failure: state of the art. Prehosp Emerg Care 2003; 7: 13–23. [DOI] [PubMed] [Google Scholar]
  • 32. Poole‐Wilson PA. Treatment of acute heart failure: out with the old, in with the new. JAMA 2002; 287: 1578–1580. [DOI] [PubMed] [Google Scholar]
  • 33. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003; 24: 464–474. [DOI] [PubMed] [Google Scholar]
  • 34.National Institutes of Health, Clinical Trials Web site. Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE‐AHF Study). http://www.clinicaltrials.gov/ct2/show/NCT00577135?term=DOSE‐AHF&rank=1. Accessed September 24, 2009.
  • 35. Cody RJ, Covit AB, Schaer GL, Laragh JH, Sealey JE, Feldschuh J. Sodium and water balance in chronic congestive heart failure. J Clin Invest 1986; 77: 1441–1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Hunt SA, Abrahams WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1–e90. [DOI] [PubMed] [Google Scholar]
  • 37.European Society of Cardiology, Heart Failure Association of the ESC (HFA), European Society of Intensive Care Medicine (ESICM), et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933–989. [DOI] [PubMed] [Google Scholar]
  • 38. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006; 22: 23–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Heart Failure Society of America. Evaluation and management of patients with acute decompensated heart failure. J Card Fail 2006; 12: e86–e103. [DOI] [PubMed] [Google Scholar]
  • 40.Heart Failure Society of America. Heart failure in patients with left ventricular systolic dysfunction. J Card Fail 2006; 12: e38–e57. [DOI] [PubMed] [Google Scholar]
  • 41. Domanski M, Norman J, Pitt B, et al. Diuretic use, progressive heart failure, and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003; 42: 705–708. [DOI] [PubMed] [Google Scholar]
  • 42. Paterna S, Parrinello G, Cannizzaro S, et al. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol 2009; 103: 93–102. [DOI] [PubMed] [Google Scholar]
  • 43. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61–67. [DOI] [PubMed] [Google Scholar]
  • 44. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147: 331–338. [DOI] [PubMed] [Google Scholar]
  • 45. Walma EF, Hoes AW, van Dooren C, et al. Withdrawal of long‐term diuretic medication in elderly patients: a double blind randomised trial. BMJ 1997; 315: 464–468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. De Jonge JW, Knottnerus JA, van Zutphen WM, et al. Short term effect of withdrawal of diuretic drugs prescribed for ankle oedema. BMJ 1994; 308: 511–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Burr ML, King S, Davies HE, et al. The effects of discontinuing long‐term diuretic therapy in the elderly. Age Ageing 1977; 6: 38–45. [DOI] [PubMed] [Google Scholar]
  • 48. Myers MG, Weingert ME, Fisher RH, et al. Unnecessary diuretic therapy in the elderly. Age Ageing 1982; 11: 213–221. [DOI] [PubMed] [Google Scholar]
  • 49. Barr CS, Lang CC, Hanson J, et al. Effects of adding spironolactone to an angiotensin‐converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995; 76: 1259–1265. [DOI] [PubMed] [Google Scholar]
  • 50. Sherman LG, Liang CS, Baumgardner S, et al. Piretanide, a potent diuretic with potassium‐sparing properties, for the treatment of congestive heart failure. Clin Pharmacol Ther 1986; 40: 587–594. [DOI] [PubMed] [Google Scholar]
  • 51. Cheitlin MD, Byrd R, Benowitz N, et al. Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics. Cardiovasc Drugs Ther 1991; 5: 719–725. [DOI] [PubMed] [Google Scholar]
  • 52. Richardson A, Bayliss J, Scriven AJ, et al. Double‐blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet 1987; 2: 709–711. [DOI] [PubMed] [Google Scholar]
  • 53. Nordrehaug JE, Omsjø IH, Vollset SE. A 3‐month double‐blind cross‐over study of the effect of benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure. J Intern Med 1992; 231: 589–594. [DOI] [PubMed] [Google Scholar]
  • 54. Cowley AJ, Stainer K, Wynne RD, et al. Symptomatic assessment of patients with heart failure: double‐blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet 1986; 2: 770–772. [DOI] [PubMed] [Google Scholar]
  • 55. Boccanelli A, Zachara E, Liberatore SM, et al. Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double‐blind comparative trial. Postgrad Med J 1986; 62: 184–187. [PubMed] [Google Scholar]
  • 56. Sievert H, Offermann T, Hopf R, et al. Basic therapy of chronic heart failure with digitalis or diuretics [in German]? Dtsch Med Wochenschr 1989; 114: 363–367. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Click here for additional data file. (46.5KB, doc)

Supporting Information

Click here for additional data file. (49KB, doc)

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES